SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

45.81

41590.03

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.32

Back

Sriven Multi-Tech reports standalone net loss of Rs 0.05 crore in the December 2025 quarter

Feb 16,2026

Net Loss of Sriven Multi-Tech reported to Rs 0.05 crore in the quarter ended December 2025 as against net loss of Rs 0.16 crore during the previous quarter ended December 2024. Sales reported to Rs 0.01 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.01	0	0
OPM %	-500.00	0	-
PBDT	-0.05	-0.16	69
PBT	-0.05	-0.16	69
NP	-0.05	-0.16	69

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)